The application relates to the technical field of
blood drug concentration detection, and discloses a
blood drug concentration
analysis method based on
mass spectrometric detection, which comprises the following steps: adopting microfluidic technology in combination with
solid-phase extraction to pretreat a blood sample to obtain a concentrated solution, so as to remove interfering components and concentrate
target drug molecules; according to the physicochemical properties of the
target drug molecules, the concentrated solution is selected to flow through a
biosensor or is directly introduced into a chromatographic unit, and the
target drug molecules in the
liquid phase are converted into gas-phase ions when flowing through the
biosensor;
chromatography-
mass spectrometry is adopted to detect the gas-phase ions or the concentrated solution, so as to obtain
mass spectrum data; a
machine learning model is used to analyze the spectrum data, to identify the
drug types and calculate the concentration of the target
drug molecules, and to generate an analysis report. The method is suitable for target drugs with different physicochemical properties, simplifies the detection process, and improves the applicability and accuracy of detection.